Pharmaron Beijing Co (HKSE:03759) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:03759 Pharmaron Beijing Co Ltd HKSE:03759
93 GF Score
Price HK$23.66
GF Value HK$20.47
Valuation Modestly Overvalued
! 9 Warning Signs
View Full Analysis

What is Pharmaron Beijing Co Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:03759 vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Pharmaron Beijing Co's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaron Beijing Co Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaron Beijing Co's Short Interest distribution charts can be found below:

* The bar in red indicates where Pharmaron Beijing Co's Short Interest falls into.


HKSE:03759
93GF Score
Pharmaron Beijing Co Ltd HKSE:03759
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharmaron Beijing Co (HKSE:03759) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmaron Beijing Co stock appears to be overvalued. The current stock price of HK$23.66 is trading 15.6% above its estimated GF Value™ of HK$20.47. GuruFocus considers Pharmaron Beijing Co to be Modestly Overvalued.

Key valuation signals for HKSE:03759:

  • Short Interest:
  • GF Value™: HK$20.47 vs. price of HK$23.66 (15.6% above fair value)
  • GF Score™: 93/100 with 9 warning signs

No single metric tells the full story. See the HKSE:03759 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmaron Beijing Co Business Description

Other Exchanges 17Q1:Germany300759:China
Address 6 Tai-He Road, 8th Floor, Block 1, Beijing Economic Technological Development Area, Beijing, CHN, 100176
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry, and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. Its operating segment includes Laboratory services; CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
93GF Score

Get the complete analysis for HKSE:03759

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$23.66
Price
HK$20.47
GF Value